340B Update: HRSA Notifies Six Manufacturers That They Are In Violation Of The 340B Statute
By EsqSocial Corporation 18/05/21
Since mid-2020, many pharmaceutical manufacturers have introduced policies that scope their offering of 340B pricing, including limiting contract pharmacy arrangements and requiring covered entities to submit claims data. These policies have generated a good deal of attention generally, and a significant number of covered entities have made attendant complaints to the Health Resources and Services Administration (HRSA)......
By: Husch Blackwell LLP